587 related articles for article (PubMed ID: 25203632)
1. Transplanted Human Induced Pluripotent Stem Cell-Derived Neural Progenitor Cells Do Not Promote Functional Recovery of Pharmacologically Immunosuppressed Mice With Contusion Spinal Cord Injury.
Pomeshchik Y; Puttonen KA; Kidin I; Ruponen M; Lehtonen S; Malm T; Åkesson E; Hovatta O; Koistinaho J
Cell Transplant; 2015; 24(9):1799-812. PubMed ID: 25203632
[TBL] [Abstract][Full Text] [Related]
2. Effects of the Post-Spinal Cord Injury Microenvironment on the Differentiation Capacity of Human Neural Stem Cells Derived from Induced Pluripotent Stem Cells.
López-Serrano C; Torres-Espín A; Hernández J; Alvarez-Palomo AB; Requena J; Gasull X; Edel MJ; Navarro X
Cell Transplant; 2016 Oct; 25(10):1833-1852. PubMed ID: 27075820
[TBL] [Abstract][Full Text] [Related]
3. Beneficial Effect of Human Induced Pluripotent Stem Cell-Derived Neural Precursors in Spinal Cord Injury Repair.
Romanyuk N; Amemori T; Turnovcova K; Prochazka P; Onteniente B; Sykova E; Jendelova P
Cell Transplant; 2015; 24(9):1781-97. PubMed ID: 25259685
[TBL] [Abstract][Full Text] [Related]
4. Human-induced pluripotent stem cells generated from intervertebral disc cells improve neurologic functions in spinal cord injury.
Oh J; Lee KI; Kim HT; You Y; Yoon DH; Song KY; Cheong E; Ha Y; Hwang DY
Stem Cell Res Ther; 2015 Jun; 6(1):125. PubMed ID: 26104416
[TBL] [Abstract][Full Text] [Related]
5. Cell therapy for spinal cord injury by using human iPSC-derived region-specific neural progenitor cells.
Kajikawa K; Imaizumi K; Shinozaki M; Shibata S; Shindo T; Kitagawa T; Shibata R; Kamata Y; Kojima K; Nagoshi N; Matsumoto M; Nakamura M; Okano H
Mol Brain; 2020 Sep; 13(1):120. PubMed ID: 32883317
[TBL] [Abstract][Full Text] [Related]
6. iPSC-derived neural precursor cells: potential for cell transplantation therapy in spinal cord injury.
Nagoshi N; Okano H
Cell Mol Life Sci; 2018 Mar; 75(6):989-1000. PubMed ID: 28993834
[TBL] [Abstract][Full Text] [Related]
7. Neural stem cell mediated recovery is enhanced by Chondroitinase ABC pretreatment in chronic cervical spinal cord injury.
Suzuki H; Ahuja CS; Salewski RP; Li L; Satkunendrarajah K; Nagoshi N; Shibata S; Fehlings MG
PLoS One; 2017; 12(8):e0182339. PubMed ID: 28771534
[TBL] [Abstract][Full Text] [Related]
8. Human neural progenitors derived from integration-free iPSCs for SCI therapy.
Liu Y; Zheng Y; Li S; Xue H; Schmitt K; Hergenroeder GW; Wu J; Zhang Y; Kim DH; Cao Q
Stem Cell Res; 2017 Mar; 19():55-64. PubMed ID: 28073086
[TBL] [Abstract][Full Text] [Related]
9. Significance of remyelination by neural stem/progenitor cells transplanted into the injured spinal cord.
Yasuda A; Tsuji O; Shibata S; Nori S; Takano M; Kobayashi Y; Takahashi Y; Fujiyoshi K; Hara CM; Miyawaki A; Okano HJ; Toyama Y; Nakamura M; Okano H
Stem Cells; 2011 Dec; 29(12):1983-94. PubMed ID: 22028197
[TBL] [Abstract][Full Text] [Related]
10. Grafted Human iPS Cell-Derived Oligodendrocyte Precursor Cells Contribute to Robust Remyelination of Demyelinated Axons after Spinal Cord Injury.
Kawabata S; Takano M; Numasawa-Kuroiwa Y; Itakura G; Kobayashi Y; Nishiyama Y; Sugai K; Nishimura S; Iwai H; Isoda M; Shibata S; Kohyama J; Iwanami A; Toyama Y; Matsumoto M; Nakamura M; Okano H
Stem Cell Reports; 2016 Jan; 6(1):1-8. PubMed ID: 26724902
[TBL] [Abstract][Full Text] [Related]
11. PSA-NCAM positive neural progenitors stably expressing BDNF promote functional recovery in a mouse model of spinal cord injury.
Butenschön J; Zimmermann T; Schmarowski N; Nitsch R; Fackelmeier B; Friedemann K; Radyushkin K; Baumgart J; Lutz B; Leschik J
Stem Cell Res Ther; 2016 Jan; 7():11. PubMed ID: 26762640
[TBL] [Abstract][Full Text] [Related]
12. Long-Term Effects of Neural Precursor Cell Transplantation on Secondary Injury Processes and Functional Recovery after Severe Cervical Contusion-Compression Spinal Cord Injury.
Younsi A; Zheng G; Riemann L; Scherer M; Zhang H; Tail M; Hatami M; Skutella T; Unterberg A; Zweckberger K
Int J Mol Sci; 2021 Dec; 22(23):. PubMed ID: 34884911
[TBL] [Abstract][Full Text] [Related]
13. iPSC Transplantation increases regeneration and functional recovery after ischemic stroke in neonatal rats.
Chau MJ; Deveau TC; Song M; Gu X; Chen D; Wei L
Stem Cells; 2014 Dec; 32(12):3075-87. PubMed ID: 25132189
[TBL] [Abstract][Full Text] [Related]
14. hiPSC-derived NSCs effectively promote the functional recovery of acute spinal cord injury in mice.
Kong D; Feng B; Amponsah AE; He J; Guo R; Liu B; Du X; Liu X; Zhang S; Lv F; Ma J; Cui H
Stem Cell Res Ther; 2021 Mar; 12(1):172. PubMed ID: 33706803
[TBL] [Abstract][Full Text] [Related]
15. Applications of induced pluripotent stem cell technologies in spinal cord injury.
Nagoshi N; Okano H
J Neurochem; 2017 Jun; 141(6):848-860. PubMed ID: 28199003
[TBL] [Abstract][Full Text] [Related]
16. Selective Ablation of Tumorigenic Cells Following Human Induced Pluripotent Stem Cell-Derived Neural Stem/Progenitor Cell Transplantation in Spinal Cord Injury.
Kojima K; Miyoshi H; Nagoshi N; Kohyama J; Itakura G; Kawabata S; Ozaki M; Iida T; Sugai K; Ito S; Fukuzawa R; Yasutake K; Renault-Mihara F; Shibata S; Matsumoto M; Nakamura M; Okano H
Stem Cells Transl Med; 2019 Mar; 8(3):260-270. PubMed ID: 30485733
[TBL] [Abstract][Full Text] [Related]
17. Pre-evaluated safe human iPSC-derived neural stem cells promote functional recovery after spinal cord injury in common marmoset without tumorigenicity.
Kobayashi Y; Okada Y; Itakura G; Iwai H; Nishimura S; Yasuda A; Nori S; Hikishima K; Konomi T; Fujiyoshi K; Tsuji O; Toyama Y; Yamanaka S; Nakamura M; Okano H
PLoS One; 2012; 7(12):e52787. PubMed ID: 23300777
[TBL] [Abstract][Full Text] [Related]
18. Neuroprotective effects of human spinal cord-derived neural precursor cells after transplantation to the injured spinal cord.
Emgård M; Piao J; Aineskog H; Liu J; Calzarossa C; Odeberg J; Holmberg L; Samuelsson EB; Bezubik B; Vincent PH; Falci SP; Seiger Å; Åkesson E; Sundström E
Exp Neurol; 2014 Mar; 253():138-45. PubMed ID: 24412492
[TBL] [Abstract][Full Text] [Related]
19. Self-assembling peptides optimize the post-traumatic milieu and synergistically enhance the effects of neural stem cell therapy after cervical spinal cord injury.
Zweckberger K; Ahuja CS; Liu Y; Wang J; Fehlings MG
Acta Biomater; 2016 Sep; 42():77-89. PubMed ID: 27296842
[TBL] [Abstract][Full Text] [Related]
20. Controlling immune rejection is a fail-safe system against potential tumorigenicity after human iPSC-derived neural stem cell transplantation.
Itakura G; Kobayashi Y; Nishimura S; Iwai H; Takano M; Iwanami A; Toyama Y; Okano H; Nakamura M
PLoS One; 2015; 10(2):e0116413. PubMed ID: 25706286
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
